Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details Narrative)

v3.23.3
Warrants (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 05, 2023
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Description of repricing of the exercise price the board of directors approved the repricing of the exercise price of 2,125,000 warrants to $1.00 per share and extending the expiration date of the warrants until January 31, 2028        
Stock Based Compensation       $ 1,792,000 $ 1,915,000
Employee Stock Warrant Grant Member          
Stock Based Compensation   $ 411,000 $ 366,000 1,087,000 1,090,000
Director Member          
Stock Based Compensation   145,000 209,000 620,000 628,000
Consultants Member          
Stock Based Compensation   20,000 66,000 85,000 197,000
Warrants Member          
Stock Based Compensation   $ 576,000 $ 641,000 $ 1,792,000 $ 1,915,000